Copyright 2018 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25% per year. These returns cover a period from 1988-2017. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zack Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
Visit performance for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
Analyst Blog: Archive
3 Reasons Why You Should Snap Up Tiffany (TIF) Right Now
by Zacks Equity Research
Tiffany (TIF) is steadily introducing jewelry designs, watch collection and fragrance.
FOSL URBN SCVL
Target (TGT) Continues Same-Day Delivery War with WMT & AMZN
by Zacks Equity Research
Target (TGT) is trying to gain customers by coming up with new service offerings. The company is going the extra mile to provide the same-day delivery option to customers.
AMZN WMT TGT COST
Here's Why You Should Invest in Continental Resources Now
by Zacks Equity Research
Continental Resources (CLR) has strong footprint in some of the premier oil and gas producing properties in the United States.
APC ECR CLR WRD
Boeing (BA) Wins $1.5B Navy Deal for F/A and E/A18 Aircraft
by Zacks Equity Research
While Boeing's (BA) F/A-18 jets help the U.S. navy to perform virtually every mission in the tactical spectrum, EA-18 jets carry out conventional strike missions and suppress enemy air defenses.
NOC BA WAIR TXT
Matador Resource's Subsidiary Inks Deal to Dispose Saltwater
by Zacks Equity Research
Matador Resources' (MTDR) signs agreement with a major producer in Eddy County to gather and dispose salt water.
CVRR PAA MTDR OXY
5 Reasons to Add TransUnion (TRU) Stock to Your Portfolio
by Zacks Equity Research
TransUnion (TRU) has an attractive business model with highly recurring and diversified revenue streams, significant operating leverage and low capital requirements.
TRU FLT WEX MA
Viasat Adds TBI as Master Agent to Increase Broadband Access
by Zacks Equity Research
Viasat (VSAT) collaborates with TBI to offer businesses with increased broadband access.
MSI UBNT CMTL VSAT
Dr. Reddy's/Mylan Get FDA Nod for First Generic of Suboxone
by Zacks Equity Research
Dr. Reddy's (RDY) and Mylan announced that the FDA approved the first generic version of Suboxone (Buprenorphine and Naloxone Sublingual Film) under-the-tongue film for the treatment of opioid addiction.
ILMN AGLE RDY MYL
AT&T, Time Warner Tie the Knot, for Better or Worse
by Sejuti Banerjea
AT&T (T) has closed the Time Warner (TWX) acquisition.
TWX DIS AMZN NFLX FB GOOGL T CMCSA
Facebook Roundup: Gaming Hub, Marketplace Ads, Data Sharing
by Sejuti Banerjea
Facebook (FB) has launched a new gaming video hub and Marketplace ads even as regulators the world over investigate its data sharing practices.
AMZN BIDU FB TTD GOOGL UDIRF
Roche Announces Positive Data on Gazyva and MS Drug Ocrevus
by Zacks Equity Research
Roche (RHHBY) announced positive long-term data on leukemia drug Gazyva and MS drug Ocrevus.
RHHBY NVS AMGN BIIB
Will Travel Retail, Online Continue to Drive Estee Lauder?
by Zacks Equity Research
Estee Lauder (EL) has been performing well, courtesy of its focus on buyouts, emerging market growth and strong online presence among others. However, soft U.S. store traffic has been a worry.
IPAR HELE EL CHEF
Alliant Energy Furthers Green Plans, Partners EDF Renewables
by Zacks Equity Research
Alliant Energy (LNT) is on track to meet its target of adding 1,000 MW of new wind-generation assets in its portfolio by 2020.
IDA NRG LNT TERP
Baker Hughes Wins Cheniere's Corpus Christi Expansion Deal
by Zacks Equity Research
Baker Hughes (BHGE) to provide six gas turbines and several compressors for the third LNG train in South Texas.
DK HFC LNG BHGE
Here's Why You Must Add Prudential (PRU) to Your Portfolio
by Zacks Equity Research
Prudential (PRU) vies to earn better returns for investors on the back of seven factors.
AIZ CI KMPR PRU
Here's Why You Should Dump Cirrus Logic From Your Portfolio
by Zacks Equity Research
Declining smartphone demand and overdependence on Apple are proving to be costly for Cirrus Logic (CRUS).
WDC AAPL CRUS NVDA
FuelCell Energy Receives 2 Energy Projects in Connecticut
by Zacks Equity Research
FuelCell Energy (FCEL) will generate 22.2 MW fuel cell energy and become part of DEEP's long-term goal to reduce emission.
GM BLDP PLUG FCEL
Here's Why Investors Should Retain Clean Harbors (CLH) Stock
by Zacks Equity Research
Clean Harbors (CLH) continues to grow with the help of multiple acquisitions in both new and existing markets.
FLT WEX MA CLH
Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III
by Zacks Equity Research
Glaxo's (GSK) two late-stage studies testing its two-drug HIV regimen of dolutegravir (Tivicay) and lamivudine showed non-inferiority to a standard three-drug regimen
PFE JNJ GSK MYL
Aptiv (APTV) Acquires KUM, Boosts Asia Pacific Presence
by Zacks Equity Research
Apart from enhancing Aptiv's (APTV) Asia Pacific presence, the buyout of KUM is expected to positively impact Aptiv's bottom line in 2018.
BCOR DLPH MA APTV
BioMarin Begins Pediatric Study on Achondroplasia Candidate
by Zacks Equity Research
BioMarin Pharmaceutical (BMRN) initiates phase II study on vosoritide for the treatment of achondroplasia in infants and children up to five years of age.
BMRN ENDP RDY CRSP
Logitech (LOGI) Hits 52-Week High on Solid Growth in Gaming
by Zacks Equity Research
Logitech International (LOGI) continues to benefit from broad-based growth across its retail business, with strong momentum in Gaming, Video Collaboration, Tablet & Accessories and Smart Home segments.
WDC LOGI MLNX MU
CME Group (CME) Prices $1.2 Billion Senior Unsecured Notes
by Zacks Equity Research
CME Group's (CME) new issuance speaks volumes for its wise move to capitalize on a low interest rate environment to obtain funds.
AB AEL CME NDAQ
Jabil's (JBL) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Jabil's (JBL) fiscal third-quarter 2018 results benefit from the company's continuous diversification efforts.
TXN NVDA MU JBL
UnitedHealth Senior Notes Receive Rating Action From Moody's
by Zacks Equity Research
Moody's assigns rating to $4 billion senior unsecured debt of UnitedHealth (UNH). Outlook remains stable.
HUM UNH WCG ANTM